Analytical Data
-
Gene name
PCDHa4
- Application
-
Alternative Names
CNR1; CRNR1; CNRN1
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O88689
-
Expression Region
Gln30~Gly217
-
Molecular Weight
27kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PCDHa4, a member of the polycystic kidney disease (PKD) family of proteins, has garnered significant attention in recent years due to its potential role in neural development and synaptic function. Research indicates that PCDHa4 may be involved in cell adhesion processes within the nervous system, influencing neuronal connectivity and synaptic stability. Moreover, mutations or dysregulation of PCDHa4 have been associated with various neurological disorders, highlighting its importance in the maintenance of healthy neural tissues. The production of recombinant PCDHa4 protein allows researchers to study its structure-function relationships and interactions with other neural proteins in vitro. This is essential for understanding the mechanisms by which PCDHa4 contributes to neural development and the pathogenesis of related diseases. Investigating the functional characteristics of PCDHa4 through recombinant technology not only enhances our understanding of its biological significance but also opens up new avenues for potential therapeutic interventions targeting neurological disorders linked to its dysfunction. As such, the recombinant PCDHa4 protein is a crucial tool for advancing our knowledge of neuronal biology and developing strategies to combat related health issues.
